Association Between Germline Mutations in BRF1, a Subunit of the RNA Polymerase III Transcription Complex, and Hereditary Colorectal Cancer.

BACKGROUND & AIMS Although there is a genetic predisposition to colorectal cancer (CRC), few of the genes that affect risk have been identified. We performed whole-exome sequence analysis of individuals in a high-risk family without mutations in genes previously associated with CRC risk to identify variants associated with inherited CRC. METHODS We collected blood samples from 3 relatives with CRC in Spain (65, 62, and 40 years old at diagnosis) and performed whole-exome sequence analyses. Rare missense, truncating or splice-site variants shared by the 3 relatives were selected. We used targeted pooled DNA amplification followed by next generation sequencing to screen for mutations in candidate genes in 547 additional hereditary and/or early-onset CRC cases (502 additional families). We carried out protein-dependent yeast growth assays and transfection studies in the HT29 human CRC cell line to test the effects of the identified variants. RESULTS A total of 42 unique or rare (population minor allele frequency below 1%) nonsynonymous genetic variants in 38 genes were shared by all 3 relatives. We selected the BRF1 gene, which encodes an RNA polymerase III transcription initiation factor subunit for further analysis, based on the predicted effect of the identified variant and previous association of BRF1 with cancer. Previously unreported or rare germline variants in BRF1 were identified in 11 of 503 CRC families, a significantly greater proportion than in the control population (34 of 4300). Seven of the identified variants (1 detected in 2 families) affected BRF1 mRNA splicing, protein stability, or expression and/or function. CONCLUSIONS In an analysis of families with a history of CRC, we associated germline mutations in BRF1 with predisposition to CRC. We associated deleterious BRF1 variants with 1.4% of familial CRC cases, in individuals without mutations in high-penetrance genes previously associated with CRC. Our findings add additional evidence to the link between defects in genes that regulate ribosome synthesis and risk of CRC.

[1]  Dina Grohmann,et al.  Molecular mechanisms of Bdp1 in TFIIIB assembly and RNA polymerase III transcription initiation , 2017, Nature Communications.

[2]  Laura Valle,et al.  Recent Discoveries in the Genetics of Familial Colorectal Cancer and Polyposis. , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[3]  T. Markello,et al.  BRF1 mutations in a family with growth failure, markedly delayed bone age, and central nervous system anomalies , 2017, Clinical genetics.

[4]  P. Broderick,et al.  Validation of Recently Proposed Colorectal Cancer Susceptibility Gene Variants in an Analysis of Families and Patients-a Systematic Review. , 2017, Gastroenterology.

[5]  M. Nöthen,et al.  Exome Sequencing Identifies Biallelic MSH3 Germline Mutations as a Recessive Subtype of Colorectal Adenomatous Polyposis. , 2016, American journal of human genetics.

[6]  M. Lindström,et al.  Role of ribosomal protein mutations in tumor development (Review) , 2016, International journal of oncology.

[7]  I. Irminger-Finger,et al.  Cancer predisposing BARD1 mutations affect exon skipping and are associated with overexpression of specific BARD1 isoforms. , 2015, Oncology reports.

[8]  I. Irminger-Finger,et al.  Analysis of large mutations in BARD1 in patients with breast and/or ovarian cancer: the Polish population as an example , 2015, Scientific Reports.

[9]  J. Shendure,et al.  A germline homozygous mutation in the base-excision repair gene NTHL1 causes adenomatous polyposis and colorectal cancer , 2015, Nature Genetics.

[10]  J. Potter,et al.  Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry. , 2015, JAMA Oncology.

[11]  Tirso Pons,et al.  Structure-PPi: a module for the annotation of cancer-related single-nucleotide variants at protein–protein interfaces , 2015, Bioinform..

[12]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[13]  A. Reymond,et al.  BRF1 mutations alter RNA polymerase III–dependent transcription and cause neurodevelopmental anomalies , 2015, Genome research.

[14]  Á. Carracedo,et al.  Whole-exome sequencing identifies rare pathogenic variants in new predisposition genes for familial colorectal cancer , 2014, Genetics in Medicine.

[15]  I. Irminger-Finger,et al.  Cancer predisposing BARD 1 mutations affect exon skipping and are associated with overexpression of specific BARD 1 isoforms , 2015 .

[16]  S. Scherer,et al.  Germline Mutation of RPS20, Encoding a Ribosomal Protein, Causes Predisposition to Hereditary Nonpolyposis Colorectal Carcinoma Without DNA Mismatch Repair Deficiency , 2014, Gastroenterology.

[17]  L. Valle.  Genetic predisposition to colorectal cancer: where we stand and future perspectives. , 2014, World journal of gastroenterology.

[18]  R. Sanz-Pamplona,et al.  Comprehensive molecular characterisation of hereditary non-polyposis colorectal tumours with mismatch repair proficiency. , 2014, European journal of cancer.

[19]  Jana Marie Schwarz,et al.  MutationTaster2: mutation prediction for the deep-sequencing age , 2014, Nature Methods.

[20]  Yang Zhang,et al.  The I-TASSER Suite: protein structure and function prediction , 2014, Nature Methods.

[21]  Peter Donnelly,et al.  Germline mutations in the proof-reading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas , 2012, Nature Genetics.

[22]  C. Lázaro,et al.  Comprehensive functional assessment of MLH1 variants of unknown significance , 2012, Human mutation.

[23]  Marianne Rooman,et al.  Structure-based mutant stability predictions on proteins of unknown structure. , 2012, Journal of biotechnology.

[24]  P. Rosenberg,et al.  Incidence of neoplasia in Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry. , 2012, Blood.

[25]  Juliane C. Dohm,et al.  Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia , 2011, Nature.

[26]  A. Gonzalez-Perez,et al.  Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel. , 2011, American journal of human genetics.

[27]  Å. Borg,et al.  Cancer predisposing BARD1 mutations in breast–ovarian cancer families , 2011, Breast Cancer Research and Treatment.

[28]  M. Rooman,et al.  PoPMuSiC 2.1: a web server for the estimation of protein stability changes upon mutation and sequence optimality , 2011, BMC Bioinformatics.

[29]  S. Cabarcas,et al.  RNA polymerase III transcription in cancer: the BRF2 connection , 2011, Molecular Cancer.

[30]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[31]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[32]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[33]  C. Béroud,et al.  Human Splicing Finder: an online bioinformatics tool to predict splicing signals , 2009, Nucleic acids research.

[34]  S. Henikoff,et al.  Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm , 2009, Nature Protocols.

[35]  Lynne Marshall,et al.  Non-coding RNA production by RNA polymerase III is implicated in cancer , 2008, Nature Reviews Cancer.

[36]  D. Beach,et al.  Cellular senescence bypass screen identifies new putative tumor suppressor genes , 2008, Oncogene.

[37]  Shuangye Yin,et al.  Eris: an automated estimator of protein stability , 2007, Nature Methods.

[38]  M. Michael Gromiha,et al.  CUPSAT: prediction of protein stability upon point mutations , 2006, Nucleic Acids Res..

[39]  François Stricher,et al.  The FoldX web server: an online force field , 2005, Nucleic Acids Res..

[40]  Piero Fariselli,et al.  Predicting protein stability changes from sequences using support vector machines , 2005, ECCB/JBI.

[41]  S. Hahn,et al.  The zinc ribbon domains of the general transcription factors TFIIB and Brf: conserved functional surfaces but different roles in transcription initiation. , 2000, Genes & development.

[42]  R. Kobayashi,et al.  RNA polymerase III transcription from the human U6 and adenovirus type 2 VAI promoters has different requirements for human BRF, a subunit of human TFIIIB , 1996, Molecular and cellular biology.

[43]  Z. Wang,et al.  Structure and function of a human transcription factor TFIIIB subunit that is evolutionarily conserved and contains both TFIIB- and high-mobility-group protein 2-related domains. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[44]  S. Hahn,et al.  A yeast TFIIB-related factor involved in RNA polymerase III transcription. , 1992, Genes & development.